Holen Sie sich die Stockscreener-App
1.79
7.83%
0.13
Handel nachbörslich:
1.79
Schlusskurs vom Vortag:
$1.66
Offen:
$1.72
24-Stunden-Volumen:
519.89K
Relative Volume:
3.19
Marktkapitalisierung:
$31.01M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+0.56%
1M Leistung:
-26.64%
6M Leistung:
-57.98%
1J Leistung:
-42.44%
1-Tages-Spanne:
$1.675
$1.80
1-Wochen-Bereich:
$1.53
$1.8027
52-Wochen-Spanne:
$0.95
$4.74
Mural Oncology Plc Stock (MURA) Company Profile
Firmenname
Mural Oncology Plc
Sektor
Branche
Telefon
353 1 905 8020
Adresse
10 EARLSFORT TERRACE, DUBLIN 2
Vergleichen Sie MURA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MURA
Mural Oncology Plc
|
1.79 | 28.76M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Mural Oncology Plc Stock (MURA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-25 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-03-25 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2024-06-28 | Eingeleitet | Rodman & Renshaw | Buy |
| 2024-04-04 | Eingeleitet | Morgan Stanley | Overweight |
Mural Oncology Plc Aktie (MURA) Neueste Nachrichten
Form 8.3Mural Oncology plc - Business Wire
Citadel Group discloses 1.17% stake in Mural Oncology - Investing.com India
Citadel Group discloses 1.17% stake in Mural Oncology By Investing.com - Investing.com South Africa
Candlestick Reversal Detected on Mural Oncology plc’s ChartAlpha Driven Watchlist With Alerts Published - metal.it
Citadel Group discloses 1.23% stake in Mural Oncology By Investing.com - Investing.com Australia
Citadel Group discloses 1.23% stake in Mural Oncology - Investing.com
Mural Oncology Q2 Loss Surges 49%, Ending All R&D Activities and Exploring Strategic Alternatives. - AInvest
Mural Oncology (MURA) Q2 Loss Widens 49% - The Motley Fool
Mural Oncology announces second quarter financial results and provides business update - MarketScreener
Mural Oncology plc SEC 10-Q Report - TradingView
Mural Oncology Slashes Workforce by 90%, Explores Sale with $77M Cash Runway - Stock Titan
How strong is Mural Oncology plc company’s balance sheetUnlock market-leading stock analysis - jammulinksnews.com
What are analysts’ price targets for Mural Oncology plc in the next 12 monthsPowerful market insights - Jammu Links News
Is it the right time to buy Mural Oncology plc stockStrongest growth potential - Jammu Links News
What analysts say about Mural Oncology plc stockNavigate the market with precision tools - Jammu Links News
What institutional investors are buying Mural Oncology plc stockGet real-time alerts on top stocks - Jammu Links News
What makes Mural Oncology plc stock price move sharplyHigh-profit capital plays - Jammu Links News
Mural Oncology plc Stock Analysis and ForecastDiscover breakthrough trading strategies - Jammu Links News
How volatile is Mural Oncology plc stock compared to the marketEarnings Report Alerts To Watch Now - Jammu Links News
Mural Oncology plc Forms Bullish Flag — Upside AheadDaily Stock Market Swing Alerts Highlight Key Movers - beatles.ru
Is Mural Oncology plc the Top Chart Pick This WeekAlpha Focused Technical Trade Signals Gain Attention - metal.it
Can Mural Oncology plc Regain Lost Ground This QuarterTechnical Stock Breakout Predictions Signal Entry Points - metal.it
Support Zone Holds Steady for Mural Oncology plc After DipShort Term Trading Opportunity Watch Sees Shift - metal.it
Disclosure of Opening Position in Mural Oncology plc by The Vanguard Group, Inc. - AInvest
Mural Oncology plc Price Targets Raised After ReboundTrade Timing Strategy With Technical Data Explained - metal.it
Mural Oncology plc Attempts Reversal From Key SupportCommunity Verified Stock Suggestions Drive Volume - metal.it
Watch for Trend Continuation in Mural Oncology plc Next WeekStock Selection With High Accuracy Based on Models - metal.it
Real Time Chart Alerts Flash Bullish on Mural Oncology plcCapital Preserving Trade Plan Templates Shared - metal.it
Should I hold or sell Mural Oncology plc stock in 2025Unlock your portfolio’s full growth potential - Jammu Links News
Mural Oncology plc Pullback Analyzed — Is It Time to ExitOversold Bounce Stock Play Ideas Gain Attention - metal.it
How Resilient Is Mural Oncology plc Stock During Economic DownturnsTop Performing Low Risk Stocks - metal.it
Does Mural Oncology plc stock perform well during market downturnsFree Predictions - jammulinksnews.com
Is Mural Oncology plc a good long term investmentUnmatched market gains - PrintWeekIndia
Will Mural Oncology plc stock benefit from interest rate changesBreakthrough profit margins - Jammu Links News
Is Mural Oncology plc stock a growth or value playBreakneck growth rates - jammulinksnews.com
Finanzdaten der Mural Oncology Plc-Aktie (MURA)
Es liegen keine Finanzdaten für Mural Oncology Plc (MURA) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):